ATE511651T1 - Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen - Google Patents

Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Info

Publication number
ATE511651T1
ATE511651T1 AT07007262T AT07007262T ATE511651T1 AT E511651 T1 ATE511651 T1 AT E511651T1 AT 07007262 T AT07007262 T AT 07007262T AT 07007262 T AT07007262 T AT 07007262T AT E511651 T1 ATE511651 T1 AT E511651T1
Authority
AT
Austria
Prior art keywords
transglutaminase
autoimmune diseases
diagnostic indicator
novel antigen
diagnostic
Prior art date
Application number
AT07007262T
Other languages
English (en)
Inventor
Daniel Aeschlimann
Marios Hadjivassilliou
Original Assignee
Zedira Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zedira Gmbh filed Critical Zedira Gmbh
Application granted granted Critical
Publication of ATE511651T1 publication Critical patent/ATE511651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07007262T 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen ATE511651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07007262A EP1978364B1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
ATE511651T1 true ATE511651T1 (de) 2011-06-15

Family

ID=38158045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07007262T ATE511651T1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Country Status (7)

Country Link
US (1) US20130196336A1 (de)
EP (1) EP1978364B1 (de)
AT (1) ATE511651T1 (de)
AU (1) AU2008234999A1 (de)
CA (1) CA2683394A1 (de)
RU (1) RU2009140980A (de)
WO (1) WO2008122432A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0900195D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis and treatment of gluten-induced autoimmune diseases
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
EP2322926A1 (de) * 2009-11-11 2011-05-18 Zedira GmbH Stabilisiertes Transglutaminase als diagnostischer Indikator für Autoimmunerkrankungen
WO2011057826A1 (en) * 2009-11-11 2011-05-19 Zedira Gmbh Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases
EP2569630A4 (de) 2010-05-13 2013-10-30 Univ New Jersey Med Diagnostische autoantikörper-profile zur erkennung und diagnose neurodegenerativer erkrankungen
CN102220337B (zh) * 2010-09-19 2012-11-14 中南大学 一种遗传性脊髓小脑共济失调相关基因
RU2441240C1 (ru) * 2010-10-05 2012-01-27 Государственное образовательное учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет" Министерства здравоохранения и социального развития Российской Федерации Способ диагностики аксонально-демиелинизирующих полиневропатий
EP2666017B1 (de) * 2011-01-20 2018-10-03 Cyrex Laboratories, LLC Verfahren und vorrichtung zum nachweis einer glutenempfindlichkeit und zu ihrer differenzierung von zöliakie
US10132817B2 (en) 2011-07-12 2018-11-20 Rowan University Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
US10393734B2 (en) * 2016-06-21 2019-08-27 Euroimmun Medizinische Labordiagnostika Ag Diagnostic coincubation assay
IT202100019616A1 (it) * 2021-07-23 2023-01-23 Univ Degli Studi Di Trieste Nuovo metodo
CN116515786B (zh) * 2023-04-26 2024-05-28 广东医科大学 一种人tgm3乙酰化多肽、抗原、抗体及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630557C2 (de) 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO2001001133A2 (en) 1999-06-28 2001-01-04 Immundiagnostik Ag Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
WO2002022830A2 (en) 2000-09-15 2002-03-21 University College Cardiff Consultants Ltd. Transglutaminase gene products
GB0103024D0 (en) * 2001-02-07 2001-03-21 Rsr Ltd Assay for Autoantibodies to tissue transglutaminase

Also Published As

Publication number Publication date
EP1978364B1 (de) 2011-06-01
WO2008122432A1 (en) 2008-10-16
US20130196336A1 (en) 2013-08-01
RU2009140980A (ru) 2011-05-20
CA2683394A1 (en) 2008-10-16
AU2008234999A1 (en) 2008-10-16
EP1978364A1 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
EA201100231A1 (ru) Диагностический анализ на основе антител
DE602007011566D1 (en) Ankheit
WO2007117444A3 (en) Protein detection by aptamers
EP2539712A1 (de) Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
DE602006007703D1 (de) Verbesserte immuntestverfahren
DE602006011896D1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
EA201390150A1 (ru) Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
EA201001874A1 (ru) Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты
WO2011143574A3 (en) Plasma biomarkers for diagnosis of alzheimer's disease
WO2007147074A3 (en) Use of highly parallel snp genotyping for fetal diagnosis
DK1831699T3 (da) Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
EP2261367A3 (de) Expressionsmarker für entzündliche darmkrankheiten
EP2757160A3 (de) Genexpressionsmarker für Morbus Crohn
DE602007007209D1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EA201370063A1 (ru) Фосфолипидом рака
CY1123265T1 (el) Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς
WO2010041149A3 (en) Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
WO2009114699A3 (en) High molecular weight ngal as a biomarker for chronic kidney disease
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
MX2012001559A (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
MX343873B (es) Ensayo de diagnostico de anticuerpo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties